GT

Genelabs Technologies

Request removal

Genelabs is a biopharmaceutical company focused on the discovery and development of novel compounds for infectious diseases. In addition to a late-stage drug candidate for Hepatitis E partnered with GlaxoSmithKline, the company is advancing multiple partnered and proprietary compounds designed to selectively inhibit replication of the hepatitis C virus, targeting the HCV viral proteins - NS5B polymerase, NS4B, and NS5A. In January 2009 Genelabs was bought by GlaxoSmithKline.

Get valid emails for people working at Genelabs Technologies and 200M other companies
20 free emails each month. No credit card required.
500M
Business Profiles
20M
Company Profiles
200M
Email addresses
98%+
Email Delivery
Genelabs Technologies's headquarter address
Genelabs Technologies's industries
research
Genelabs Technologies's technology
CloudFlare Hosting Cloudflare DNS Google Font API Mobile Friendly WordPress.org
People working at Genelabs Technologies
KF
Kevin Fung
Senior Research Associate III
LL
Lillian Lou
Project Director
United States
AL
Amy Lin
Technology Specialist
United States
BB
Barbara Bivens
SR. MANAGER, PURCHASING
United States
MC
Mark Cunningham
Scientist III
FD
Fred Driscoll
CEO
United States
LA
Lida Antonian
Senior Director
United States
BB
Barbara Bivens
Sr. Manager, Purchasing & Materials
United States
JK
Judy Keller
Director, Corporate Services
United States
JB
Jill Bechtel
Scientist III
United States
You can find 24 people working at Genelabs Technologies on FinalScout. Create a free account to view details including email addresses.
Find emails from LinkedIn for free
20 free emails each month. No credit card required.
Regular search results
Search for leads on linkedin.com and scrape the search results
Sales Navigator search results
Search for leads in LinkedIn sales navigator and scrape the search results
Group members
Scrape members from any LinkedIn group without joining it
Event attendees
Scrape event attendees from any LinkedIn event
Directory